S
SANA
Sana Biotechnology, Inc.
3.35
-0.04-1.32%Opening15:06 08/19 EDT
OPEN/PREV CLOSE3.380/3.400
TODAY RANGE3.240-3.395
VOL2.64M
MARKET CAP756.74M
52 WEEK RANGE1.260-7.30
AVG VOL (3M)5.67M
% TURNOVER1.17%
TURNOVER--
P/E (TTM)-3.1550
% RANGE4.57%
EPS(TTM)-1.0634
P/E(FORWARD)-3.7697
P/B6.31
BVPS0.5317
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP689.75M
SHARES OUTSTANDING225.56M
NEXT EARNINGS11/06-11/10
FREE FLOAT205.59M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Seeking Alpha·2d ago
Beam Therapeutics: A Slow-Developing Story
TipRanks·6d ago
Sana Biotechnology (SANA) Gets a Buy from Citi
TipRanks·08/11 20:55
Sana Biotechnology reports Q2 EPS (16c), consensus (21c)
Seeking Alpha·08/11 20:45
Sana Biotechnology Non-GAAP EPS of -$0.39
Dow Jones·08/11 20:33
*Sana Biotechnology Sees Expected Cash Runway Into 2H of 2026 >SANA
Benzinga·08/11 20:17
Sana Biotechnology Q2 Adj. EPS $(0.16) Beats $(0.21) Estimate
Dow Jones·08/11 20:14
*Sana Biotechnology 2Q Loss/Shr 39c >SANA
Dow Jones·08/11 20:14
*Sana Biotechnology 2Q Loss $93.8M >SANA
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number : +852 3852 8500Service Email : service@webull.hkBusiness Cooperation : marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.